Nanobiotix launches $30m placing to fund clinical trials, repay debt

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Nanobiotix launches $30m placing to fund clinical trials, repay debt

biotech.jpg

French biotech company is raising capital for R&D and debt refinancing

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article